Ianos, R.D.; Iancu, M.; Pop, C.; Lucaciu, R.L.; Hangan, A.C.; Rahaian, R.; Cozma, A.; Negrean, V.; Mercea, D.; Procopciuc, L.M.
Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus. Medicina 2024, 60, 1841.
https://doi.org/10.3390/medicina60111841
AMA Style
Ianos RD, Iancu M, Pop C, Lucaciu RL, Hangan AC, Rahaian R, Cozma A, Negrean V, Mercea D, Procopciuc LM.
Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus. Medicina. 2024; 60(11):1841.
https://doi.org/10.3390/medicina60111841
Chicago/Turabian Style
Ianos, Raluca Diana, Mihaela Iancu, Calin Pop, Roxana Liana Lucaciu, Adriana Corina Hangan, Rodica Rahaian, Angela Cozma, Vasile Negrean, Delia Mercea, and Lucia Maria Procopciuc.
2024. "Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus" Medicina 60, no. 11: 1841.
https://doi.org/10.3390/medicina60111841
APA Style
Ianos, R. D., Iancu, M., Pop, C., Lucaciu, R. L., Hangan, A. C., Rahaian, R., Cozma, A., Negrean, V., Mercea, D., & Procopciuc, L. M.
(2024). Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus. Medicina, 60(11), 1841.
https://doi.org/10.3390/medicina60111841
